SPL — Starpharma Holdings Share News
0.000.00%
Last trade - 00:00- AU$221.83m
- AU$211.52m
- AU$12.05m
Brief: Starpharma Seeks Trading Halt
Brief: Starpharma Holdings Appoints Russell Basser As Chair
Brief: Starpharma Says Fully Underwritten Entitlement Offer To Raise A$32 MLN
Australia's Starpharma slumps to 1-1/2-month low on discounted fund raising
Australia's Starpharma hits 3-1/2-year high on FDA nod for cancer-treating therapy
Brief: Radiopharm Theranostics Ltd Co Partners With Starpharma On Research And Option Agreement To Develop Novel Radiotherapy Asset
Australia's Starpharma jumps on plans to develop novel radiotherapy treatment
Brief: Starpharma Holdings Signs Research And Option Agreement With Radiopharm Theranostics
Australia's Starpharma hits over 2-year high on cancer therapy deal
Brief: Starpharma Holdings Announces Collaboration And License Agreement With Genentech
Brief: Starpharma H1 Net Income AUD -5.4 Million
Australia's Starpharma falls on withdrawing marketing application for nasal spray
Brief: Starpharma Withdraws Application For Marketing Of Spl7013 Nasal Spray In Australia
Brief: Starpharma FY Net Loss A$8.2 Mln
Australia's Starpharma rises on cost-cutting measures
Brief: Starpharma Says Implemented Changes Expected To Reduce Fixed Costs By A$2M By FY25
Australia's Starpharma jumps on partnership to develop new company
Brief: Starpharma Holdings Says Medicxi Will Fund Petalion With Initial Investment Of Up To US$25 MLN
Brief: Starpharma Completes Formal Dispute Resolution Process With FDA In Relation To Vivagel BV